The American College of Physicians is publishing a new guideline for the treatment of depression in Annals of Internal Medicine. ACP found no substantial differences in efficacy or quality of life among “second-generation” antidepressants used to treat depressive disorders such as major depressive disorder.
Popularity: unranked [?]
Related posts:
- News From Annals Of Internal Medicine, Nov. 18, 2008, Issue
- Northwestern Research Finds Antidepressant Drugs Aim At Wrong Target
- Auspex Pharmaceuticals Announces Positive Results From Clinical Study Of SD-254, A Next-Generation Potential Treatment For Depression
- Auspex Pharmaceuticals Announces Positive Results From Clinical Study Of SD-254, A Next-Generation Potential Treatment For Depression
- Safety Test Results On Children’s Drugs Not Always Reaching Physicians Study Finds
Comments
No Responses to “American College Of Physicians Finds No Substantial Differences Among "Second-Generation" Antidepressant Drugs”